Back

A novel electrocardiographic sign to differentiate posteroseptal accessory pathways ablated from the right endocardium from those requiring a left-sided or inside the coronary sinus approach

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 6: supraventricular tachycardia: new tools and techniques Diagnostic Methods EHRA Premium Access EHRA 2019

About the speaker

Photo
Mr Samuel Hunziker

Basel (Switzerland)

9 More presentations in this session

Presentation thumbnail
Mechanisms of recurrent atrial tachycardia after radiofrequency catheter ablation in patients with congenital heart disease
Miss C. Brouwer (Leiden, NL)
Abstract
Presentation thumbnail
Slow pathway localization using high resolution mapping of the triangle of Koch
Associate Professor S. Bailin (Iowa, US)
Abstract Slides Video
Presentation thumbnail
Antegrade conduction improvement with fast atrial pacing during radiofrequency ablation of atrioventricular nodal re-entrant tachycardia to predict slow pathway conduction disappearance
Doctor S. Bun (Nice, FR)
Abstract Slides Video
Presentation thumbnail
Safety, effectiveness and long-term outcome of maximum voltage-guided approach for cavotricuspid isthmus: preliminary results from LEONARDO registry
Doctor C. La Greca (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Accessory pathway localization using ultra high density mapping of the AV annulus
Associate Professor S. Bailin (Iowa, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 6: supraventricular tachycardia: new tools and techniques

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Session
How to differentiate supraventricular tachycardias in the electrophysiology lab
thumbnail
Congress Presentation
Pacing manoeuvres during sinus rhythm
thumbnail
Congress Presentation
How to differentiate an atrial tachycardia with early septal activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources